Holding the Line on Good Laboratory Practices

The mistakes we all made coming up in the industry—the “freshman effect”—were almost unavoidable. Checking and rechecking kept us in check, and this was our go-to strategy as we became experts.

Written byMark Lanfear
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

The mistakes we all made coming up in the industry—the “freshman effect”—were almost unavoidable. Checking and rechecking kept us in check, and this was our go-to strategy as we became experts. That safety net all comes down to the three schoolhouse Rs, and it can save our industry a significant amount of money.

Why? The biggest pharmaceutical companies spent billions on research and development last year, and the money was largely invested in the three main processes needed under the stringent controls of the manufacturing of medicines: lab testing, preclinical testing, and clinical trials.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

About the Author

Related Topics

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image